On September 26, 2025, President Trump announced a 100% tariff on pharmaceutical products unless companies are "building their pharmaceutical manufacturing plants in America." This declaration follows a trend where large-cap technology companies have announced over $600 billion in investments in the U.S. to avoid tariffs.
Trump"s statement explicitly targets pharmaceutical companies that do not establish manufacturing facilities in the United States. He indicated that widespread announcements regarding new pharmaceutical plants in the U.S. are expected within the next 48 to 72 hours. The President"s goal is to encourage increased investment in the U.S. pharmaceutical sector.
This announcement comes amid ongoing discussions about tariffs and their impact on various industries. For further context, recent developments in related political matters include the FBI revealing it embedded 275 plainclothes agents in the January 6 crowds, which can be found in previous reports.